Providence Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.01M Buy
101,234
+10,535
+12% +$834K 1.47% 17
2025
Q1
$8.14M Buy
90,699
+15,452
+21% +$1.39M 1.69% 11
2024
Q4
$7.49M Buy
75,247
+64,878
+626% +$6.45M 1.52% 12
2024
Q3
$1.18M Hold
10,369
0.23% 82
2024
Q2
$1.28M Sell
10,369
-461
-4% -$57.1K 0.28% 81
2024
Q1
$1.43M Hold
10,830
0.31% 82
2023
Q4
$1.18M Buy
10,830
+799
+8% +$87.1K 0.28% 84
2023
Q3
$1.03M Buy
10,031
+161
+2% +$16.6K 0.27% 87
2023
Q2
$1.14M Sell
9,870
-40
-0.4% -$4.62K 0.29% 84
2023
Q1
$1.05M Sell
9,910
-25,139
-72% -$2.67M 0.28% 82
2022
Q4
$3.92M Sell
35,049
-3,233
-8% -$361K 1.06% 44
2022
Q3
$3.32M Buy
38,282
+538
+1% +$46.7K 1% 53
2022
Q2
$3.49M Sell
37,744
-52,081
-58% -$4.82M 1.02% 46
2022
Q1
$7.36M Buy
89,825
+8,597
+11% +$705K 1.8% 7
2021
Q4
$6.23M Buy
81,228
+409
+0.5% +$31.3K 1.72% 14
2021
Q3
$6.07M Buy
80,819
+8,704
+12% +$654K 1.89% 10
2021
Q2
$5.61M Buy
72,115
+1,001
+1% +$77.8K 1.81% 14
2021
Q1
$5.23M Buy
71,114
+7,810
+12% +$574K 1.9% 10
2020
Q4
$4.94M Buy
63,304
+1,736
+3% +$135K 2.02% 8
2020
Q3
$4.87M Buy
61,568
+7,073
+13% +$560K 2.57% 6
2020
Q2
$4.02M Sell
54,495
-45
-0.1% -$3.32K 2.28% 7
2020
Q1
$4M Buy
54,540
+18,489
+51% +$1.36M 2.41% 7
2019
Q4
$3.13M Buy
36,051
+1,991
+6% +$173K 1.68% 14
2019
Q3
$2.74M Buy
34,060
+33,836
+15,105% +$2.72M 1.61% 21
2019
Q2
$18K Buy
224
+14
+7% +$1.13K 0.01% 147
2019
Q1
$17K Sell
210
-419
-67% -$33.9K 0.01% 158
2018
Q4
$46K Sell
629
-2,384
-79% -$174K 0.03% 126
2018
Q3
$204K Sell
3,013
-33,326
-92% -$2.26M 0.13% 91
2018
Q2
$2.11M Buy
36,339
+1,257
+4% +$72.8K 1.48% 16
2018
Q1
$1.82M Buy
35,082
+8,175
+30% +$425K 1.36% 28
2017
Q4
$1.45M Buy
+26,907
New +$1.45M 1.12% 44